← back to search

Palwasha Anwari

Tata Consultancy Services (India) · GB
Area of research
Pediatrics, Perinatology and Child Health · Infectious Diseases
Research interest
Research interests include Global Maternal and Child Health, Viral gastroenteritis research and epidemiology, Health Systems, Economic Evaluations, Quality of Life, and Child Nutrition and Water Access.
h-index
29
citations
91,188
works
59
NIH funding
primary concept
Medicine
email

Recent publications

Effectiveness and impact of monovalent rotavirus vaccination in Afghanistan: a test-negative case–control analysis
The Lancet Global Health 2024cited by 7position: firstdoi
Post-marketing surveillance of intussusception after Rotarix administration in Afghanistan, 2018–2022
Vaccine 2024cited by 4position: firstdoi
The need to sustain funding for Afghanistan health system to prevent excess morbidity and mortality
Eastern Mediterranean Health Journal 2023cited by 11position: middledoi
Intussusception risk following oral monovalent rotavirus vaccination in 3 Asian countries: A self-control case series evaluation
Vaccine 2023cited by 7position: middledoi
Afghanistan's health system under the Taliban: key challenges
The Lancet 2022cited by 38position: middledoi
Potential health impact and cost-effectiveness of bivalent human papillomavirus (HPV) vaccination in Afghanistan
Vaccine 2019cited by 22position: firstdoi
Cost-effectiveness analysis for rotavirus vaccine decision-making: How can we best inform evolving and complex choices in vaccine product selection?
Vaccine 2019cited by 10position: middledoi
Re-evaluating the cost and cost-effectiveness of rotavirus vaccination in Bangladesh, Ghana, and Malawi: A comparison of three rotavirus vaccines
Vaccine 2018cited by 38position: middledoi
Global, regional, and national burden of neurological disorders during 1990–2015: a systematic analysis for the Global Burden of Disease Study 2015
The Lancet Neurology 2017cited by 2,270position: middledoi
Potential impact and cost-effectiveness of rotavirus vaccination in Afghanistan
Vaccine 2017cited by 20position: firstdoi
Global, regional, and national comparative risk assessment of 79 behavioural, environmental and occupational, and metabolic risks or clusters of risks, 1990–2015: a systematic analysis for the Global Burden of Disease Study 2015
The Lancet 2016cited by 7,777position: middledoi
Health in times of uncertainty in the eastern Mediterranean region, 1990–2013: a systematic analysis for the Global Burden of Disease Study 2013
The Lancet Global Health 2016cited by 220position: middledoi
Global, regional, and national incidence, prevalence, and years lived with disability for 301 acute and chronic diseases and injuries in 188 countries, 1990–2013: a systematic analysis for the Global Burden of Disease Study 2013
The Lancet 2015cited by 6,486position: middledoi
Global, regional, and national disability-adjusted life years (DALYs) for 306 diseases and injuries and healthy life expectancy (HALE) for 188 countries, 1990–2013: quantifying the epidemiological transition
The Lancet 2015cited by 2,006position: middledoi
Global, regional, and national prevalence of overweight and obesity in children and adults during 1980–2013: a systematic analysis for the Global Burden of Disease Study 2013
The Lancet 2014cited by 12,041position: middledoi
Global, regional, and national levels and causes of maternal mortality during 1990–2013: a systematic analysis for the Global Burden of Disease Study 2013
The Lancet 2014cited by 1,667position: middledoi
Global, regional, and national incidence and mortality for HIV, tuberculosis, and malaria during 1990–2013: a systematic analysis for the Global Burden of Disease Study 2013
The Lancet 2014cited by 990position: middledoi
Global, regional, and national levels of neonatal, infant, and under-5 mortality during 1990–2013: a systematic analysis for the Global Burden of Disease Study 2013
The Lancet 2014cited by 806position: middledoi

Grants

No grants ingested yet.

Frequent collaborators

· 7 papers (2017–2024)Andrew Clark · Airbus (Italy)6 papers (2017–2024) · 4 papers (2022–2024) · 4 papers (2017–2019)Clint Pecenka · Seattle University4 papers (2017–2019) · 3 papers (2023–2024) · 3 papers (2023–2024)Umesh D. Parashar · Centers for Disease Control and Prevention3 papers (2023–2024)Jacqueline E. Tate · National Center for Immunization and Respiratory Diseases3 papers (2023–2024) · 3 papers (2023–2024)Naor Bar‐Zeev · World Health Organization2 papers (2018–2019) · 2 papers (2018–2019) · 1 papers (2023–2023) · 1 papers (2023–2023) · 1 papers (2023–2023) · 1 papers (2023–2023) · 1 papers (2019–2019) · 1 papers (2023–2023) · 1 papers (2023–2023) · 1 papers (2018–2018)